Physician profile
Charles W Murphy
NPI 1639178908
$3,168.94
in general payments reported to CMS, 2019-2025
18 companies · $91.78 in 2025
The $91.78 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $159 · 2021: $489 · 2022: $761 · 2023: $784 · 2024: $462 · 2025: $91.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,337.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $632.77 | 2021-2023 | Senza |
| Medtronic, INC. | $595.52 | 2021-2024 | Intellis Adaptivestim, Vanta Adaptivestim |
| Abbott Laboratories | $417.45 | 2023-2025 | Octrode, Proclaim |
| Boston Scientific Corporation | $330.97 | 2021-2025 | Intracept |
| Collegium Pharmaceutical, INC. | $214.17 | 2019-2025 | Xtampza |
| Intuitive Surgical, INC. | $193.10 | 2019 | |
| Medtronic USA, INC. | $172.42 | 2019-2020 | |
| Abbvie INC. | $121.49 | 2022-2024 | |
| Galderma Laboratories, L.P. | $116.09 | 2020-2024 | Dysport |
| Relievant Medsystems, INC. | $102.35 | 2022 | |
| Merz North America, INC. | $73.68 | 2019 | |
| Allergan, INC. | $45.79 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.89 | 2020-2021 | |
| Azurity Pharmaceuticals, INC. | $33.55 | 2023-2024 | Horizant, Horizant |
| Si-Bone, INC. | $26.37 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.31 | 2023 | |
| Assertio Therapeutics, INC. | $17.82 | 2020 | |
| Scilex Pharmaceuticals INC. | $15.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.